NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - Eton Pharmaceuticals, Inc. - 8.01 / 9.01
Filed:
2026-04-27
AccNo:
0001437749-26-013369
Size:
186 KB
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
发布时间04/27 11:05 UTC
首次发现04/27 11:11 UTC
热度104.0
重要度52
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 749 字符
Form 8-K - Current report: SEC Accession No. 0001437749-26-013369
Filing Date: 2026-04-27
Accepted: 2026-04-27 07:05:10
Documents: 14
Period of Report: 2026-04-27
Items: Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Eton Pharmaceuticals, Inc. (Filer) CIK : 0001710340 (see all company filings) EIN. : 371858472 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 26896471 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 8-K | eton20260401_8k.htm iXBRL | 8-K
2 | EXHIBIT 99.1 PRESS RELEASE RELATING TO ET-700. | ex_940424.htm | EX-99.1
7 | etonlogo1.jpg | GRAPHIC | 5268
3 | XBRL TAXONOMY EXTENSION SCHEMA | eton-20260427.xsd | EX-101.SCH